Dignitana Investor Relations Material
Latest events
Q1 2025
22 May, 2025
Q4 2024
20 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dignitana
Access all reports
Dignitana AB is a Swedish medical technology company that specializes in developing and marketing the DigniCap Scalp Cooling System. This system is designed to reduce hair loss in patients undergoing chemotherapy, primarily for solid tumors such as breast cancer. The DigniCap is FDA-cleared and works by cooling the scalp to minimize hair loss during treatment, improving patient comfort and well-being. The company is headquartered in Lund, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
DIGN
Country
🇸🇪 Sweden